Hasselbalch H, Lisse I
Department of Medicine, Gentofte University Hospital, Denmark.
Eur J Haematol. 1991 May;46(5):285-9. doi: 10.1111/j.1600-0609.1991.tb01540.x.
A sequential histological study of bone marrow biopsies from 36 patients with idiopathic myelofibrosis was performed to investigate the accumulation of connective tissue in the bone marrow during the course of the disease and the influence of therapy on this process. The degree of bone marrow fibrosis was graded semiquantitatively from 0 (normal) to +5 (extensive collagen fibrosis and ostemyelosclerosis). The median interval between the first and final biopsy was 25 months (range 3 to 103) in patients with chronic idiopathic myelofibrosis and 2 months (range 1 to 14) in patients with a syndrome of acute myelofibrosis. In most patients with chronic IMF the bone marrow fibrosis remained unchanged. Regression of bone marrow fibrosis in 9 patients with chronic IMF was associated with immunosuppressive/-cytotoxic treatment or splenectomy. Severe bone marrow fibrosis completely resolved during intensive chemotherapy of a patient with acute myelofibrosis. No relationship existed between spleen size and the degree of bone marrow fibrosis.
对36例特发性骨髓纤维化患者的骨髓活检进行了序贯组织学研究,以调查疾病过程中骨髓结缔组织的积累情况以及治疗对该过程的影响。骨髓纤维化程度从0(正常)到+5(广泛胶原纤维化和骨骨髓硬化)进行半定量分级。慢性特发性骨髓纤维化患者首次活检与最后一次活检的中位间隔为25个月(范围3至103个月),急性骨髓纤维化综合征患者为2个月(范围1至14个月)。在大多数慢性特发性骨髓纤维化患者中,骨髓纤维化保持不变。9例慢性特发性骨髓纤维化患者的骨髓纤维化消退与免疫抑制/细胞毒性治疗或脾切除术有关。1例急性骨髓纤维化患者在强化化疗期间严重骨髓纤维化完全消退。脾脏大小与骨髓纤维化程度之间不存在关联。